Platform development for coupled ultrasound therapy and live cell imaging

超声微泡治疗是一种新兴的医疗技术，可用于许多诊断和治疗。 治疗应用，包括治疗癌症和心脏病。基于超声波的治疗方法 超声换能器具有许多重要的优点，包括便携性和典型超声换能器的相对低的成本， 这将使这项技术得到进一步的广泛应用。但是，必须获得更多的信息 关于超声波微泡治疗对细胞和组织的影响， 将这种疗法商业化到新的应用中。因此，有很大的需求和市场， 科学家以及临床诊断实验室的仪器，允许检查的生物效应， 真实的实时超声微泡作用于细胞和组织。我们以NSERC Engage的形式寻求支持 与MD Precision Inc.合作，先进超声技术的新兴领导者， 开发和测试一种商业仪器的原型，该仪器将超声微泡治疗与 先进的显微镜这一项目的顺利完成是该型实现商业化的关键一步 的仪器，并将允许MD精密公司。成为这个新兴技术市场的领导者， 导致了这家加拿大公司的成功，以及高水平的研究和 生产岗位。

Ultrasound-microbubble therapy is an emerging medical technology, useful for many diagnostic and therapeutic applications including the treatment of cancer and heart disease. Ultrasound-based therapies have many important advantages, including the portability and relatively low cost of typical ultrasound transducers, which will allow this technology to gain further widespread use. However, more information must be obtained by scientists about the effects of ultrasound-microbubble therapy on cells and tissues to allow the widespread commercialization of this therapy to new applications. Hence, there is a large demand and market from scientists as well as clinical diagnostics labs for instruments that allow examination of the biological effects of ultrasound microbubble on cells and tissues in real time. We seek support in the form of an NSERC Engage grant to collaborate with MD Precision Inc., an emerging leader in advanced ultrasound technologies to develop and test a prototype for a commercial instrument that couples ultrasound microbubble therapy and advanced microscopy. Successful completion of this project is a key step in the commercialization of this type of instrument, and will allow MD Precision Inc. to become a leader in this emerging technology market, resulting in the success for this Canadian company as well as the creation of high level research and manufacturing positions.